clinical trial · NCT06498128
Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®
InsomniaDaridorexantNon-orexin receptor antagonist medications for insomniaNo insomnia medication
brief summary
This study will investigate pregnancy, neonatal, and infant outcomes in women exposed to QUVIVIQ during pregnancy compared to women unexposed to QUVIVIQ during pregnancy.
started
Nov 21, 2024
primary completion
Mar 1, 2033
completion
Mar 1, 2033
last updated
Dec 2, 2025
official title
QUVIVIQ® Pregnancy Registry
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol